Literature DB >> 8455960

Nitric oxide (NO) and nociceptive processing in the spinal cord.

S T Meller1, G F Gebhart.   

Abstract

There is considerable evidence to implicate N-methyl-D-aspartate (NMDA) receptor activation in the mechanisms that underly thermal hyperalgesia in the spinal cord. As many of the effects of NMDA receptor activation appear to be ultimately mediated through production of nitric oxide (NO), recent reports have begun to define the role of NO in spinal nociceptive processing. From this evidence, it is likely that NO, produced in neurons in the spinal cord that contain NO synthase, like NMDA, plays a pivotal role in multisynaptic local circuit nociceptive processing in the spinal cord. Collectively, these reports suggest that the reflex withdrawal response to noxious heat is not mediated through activation of NMDA receptors and subsequent production of NO and cGMP, but that the acute NMDA-produced facilitation of thermal reflexes is NMDA-, NO- and cGMP-mediated and that a sustained production of NO and subsequent activation of soluble guanylate cyclase (GC-S) in the lumbar spinal cord appears to be required for maintenance of the thermal hyperalgesia produced in persistent pain models. As our knowledge and understanding of the new and intriguing class of neurotransmitters typified by NO emerges, it is likely that the next few years of pain and analgesia research will focus on the cellular events underlying mechanisms of chronic pain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455960     DOI: 10.1016/0304-3959(93)90124-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  137 in total

1.  Ultrastructural localisation of NADPH-d/nNOS expression in the superior cervical ganglion of the hamster.

Authors:  C Y Tseng; J H Lue; H M Chang; C Y Wen; J Y Shieh
Journal:  J Anat       Date:  2000-10       Impact factor: 2.610

Review 2.  Pathophysiological tissue changes associated with repetitive movement: a review of the evidence.

Authors:  Ann E Barr; Mary F Barbe
Journal:  Phys Ther       Date:  2002-02

3.  Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance.

Authors:  Y A Kolesnikov; Y X Pan; A M Babey; S Jain; R Wilson; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 4.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

5.  Heterosynaptic long-term potentiation at GABAergic synapses of spinal lamina I neurons.

Authors:  Henning Fenselau; Bernhard Heinke; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

6.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

7.  Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice.

Authors:  Ozgur Gunduz; Cetin Hakan Karadag; Ahmet Ulugol
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

Review 8.  Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer.

Authors:  Xiu Chen; Peng Lu; Lin Chen; Su-jin Yang; Hong-Yu Shen; Dan-dan Yu; Xiao-hui Zhang; Shan-liang Zhong; Jian-hua Zhao; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-09-17

9.  Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans.

Authors:  H Holthusen; J O Arndt
Journal:  J Physiol       Date:  1995-08-15       Impact factor: 5.182

10.  Met-enkephalin receptor-mediated increase of membrane fluidity modulates nitric oxide (NO) and cGMP production in rat brain synaptosomes.

Authors:  G Deliconstantinos; V Villiotou; J C Stavrides
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.